Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)
Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
A woman gave birth to a baby via IVF then realized it wasn't hers. 5 months later, she lost custody.
A woman is suing a fertility clinic for transferring another couple's embryo into her uterus. They realized the error when ...
Hims & Hers Health Stock: A Millionaire-Maker in the Making?
Is Hims & Hers a millionaire-maker in the making? Yes! Or, at least, it can be. There is a possible future where Hims & Hers ...
Viral Stories on MSN2h
Mom Takes DNA Test, Results Show Kids Aren’t Hers
Exoplanet with iron rain has violent winds 'like something out of science fiction' Experts reveal how much sleep your age ...
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Analysts have recently evaluated Hims & Hers Health and provided 12-month price targets. The average target is $36.43, ...
Hims & Hers price target raised to $85 from $35 at BTIG
BTIG analyst David Larsen raised the firm’s price target on Hims & Hers (HIMS) to $85 from $35 and keeps a Buy rating on the shares. The ...
Georgia woman says she'll "never fully recover" after IVF mix-up leads to her losing custody of 5-month-old baby
A woman who gave birth to a baby boy that wasn't hers due to an embryo transfer mix-up filed a lawsuit Tuesday against a ...
Hims & Hers Stock Is On Fire, But Is It a Bubble?
Shares of Hims & Hers (NYSE: HIMS) stock are up nearly 500% in the past year, but is the stock in bubble territory, or is there still growth ahead? Travis Hoium tackles that question plus the ...
Hims & Hers downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach downgraded Hims & Hers to Equal Weight from Overweight with a price target of $60, up from $42. The ...
Hosted on MSN12h
Morgan Stanley Downgrades Hims & Hers Health (HIMS)
Fintel reports that on February 18, 2025, Morgan Stanley downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from ...
Hims & Hers downgraded at Morgan Stanley on recent rally
Hims & Hers (HIMS) stock dips as Morgan Stanley downgrades the telehealth firm citing its recent rally in share price. Read more here.
What Is Driving Hims & Hers Stock Higher?
In this video, I will talk about recent updates regarding Hims & Hers Health (HIMS-1.85%). Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock ...